₨ Official source-observed price
PKR 258.16
1's
PKR 258.16 / vial/unit
✓ Official DRAP price source observed · Source checked 2026-09-23
Price Intelligence
Equivalent price position
Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →
This brandPKR 258.16/ vial/unit
Price position9% below medianvs like-for-like peer median
Peer comparators6current-price listings
🔒
MedInfoBase Pharma Pro
View Price Intelligence PRO
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Rank & percentilePeer medianFull competitor listPortfolio intelligence
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Amikacin
- Therapeutic area
- Anti-infectives
- Drug class
- Aminoglycoside antibacterials
- ATC
- J01
- Strength
- 500 mg/2 mL
- Dosage form
- Injection
- Pack
- 1's
- Registration no.
- 035255
- Price record verified
- 2026-08-07
- Latest DRAP source check
- 2026-09-23 03:19
Manufacturer
Vision Pharmaceuticals Pvt Ltd
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Traceability
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 258.16 | 2026-07-27 | 2026-08-07 | DRAP PharmaPrice Index | Current |
Same generic
Other listed brands
Aika 25 mgLINZ PHARMACEUTICALS (PVT) LTD. · PKR 178.62Aika 500 mg/2 mLLINZ PHARMACEUTICALS (PVT) LTD. · PKR 213.57Aika 100 mg/2 mLLINZ PHARMACEUTICALS (PVT) LTD. · PKR 67.96Aika 25 mgLINZ PHARMACEUTICALS (PVT) LTD. · PKR 38.83Aika 50 mgLINZ PHARMACEUTICALS (PVT) LTD. · PKR 223.27Aika 200 mg/100 mLLINZ PHARMACEUTICALS (PVT) LTD. · PKR 213.57Aika 25 mg/mLLINZ PHARMACEUTICALS (PVT) LTD. · PKR 38.83Aika 1 g/4 mLLINZ PHARMACEUTICALS (PVT) LTD. · PKR 403.83
Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.
Cite this record
Medicine record · DRAP registration 035255MedInfoBase. (2026). Bakacin 500 mg/2 mL Injection (1's), Vision Pharmaceuticals Pvt Ltd — registration and price record [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/brand/bakacin-500-mg-2-ml-035255-1s-vision-pharmaceuticals-pvt-ltd/ Data observed 7 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 035255.
MedInfoBase. Bakacin 500 mg/2 mL Injection (1's), Vision Pharmaceuticals Pvt Ltd — registration and price record [Internet]. Islamabad: MedInfoBase; 2026 [cited 2026 Sep 23]. Available from: https://medinfobase.com/brand/bakacin-500-mg-2-ml-035255-1s-vision-pharmaceuticals-pvt-ltd/ Data observed 7 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 035255.
MedInfoBase (2026) Bakacin 500 mg/2 mL Injection (1's), Vision Pharmaceuticals Pvt Ltd — registration and price record. Available at: https://medinfobase.com/brand/bakacin-500-mg-2-ml-035255-1s-vision-pharmaceuticals-pvt-ltd/ (Accessed: 23 September 2026).
"Bakacin 500 mg/2 mL Injection (1's), Vision Pharmaceuticals Pvt Ltd — registration and price record." MedInfoBase, 2026, https://medinfobase.com/brand/bakacin-500-mg-2-ml-035255-1s-vision-pharmaceuticals-pvt-ltd/. Accessed 23 Sep 2026.
MedInfoBase. 2026. "Bakacin 500 mg/2 mL Injection (1's), Vision Pharmaceuticals Pvt Ltd — registration and price record." Accessed September 23, 2026. https://medinfobase.com/brand/bakacin-500-mg-2-ml-035255-1s-vision-pharmaceuticals-pvt-ltd/.
Price and registration data on this page were observed on 7 August 2026. Records change over time, so please cite the observation date alongside the access date.